Grey Matters Health Inc.
AGNPF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.14M
Close$
$0.04
83.9% downside
Current Fair Value
83.9% downsideOvervalued by 83.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.14 Million |
|---|---|
| Enterprise Value | $2.88 Million |
| Earnings per Share | $-0.58 |
| Beta | 0.29 |
| Outstanding Shares | 5,422,477 |
Return
| Return on Equity | -140.39% |
|---|---|
| Return on Assets | -46.63% |
| Return on Invested Capital | -63.57% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.83 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 0.44 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 29, 2026
EPS Estimate
$-4.97
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
December 18, 2026
EPS Estimate
$-3.46
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Grey Matters Health Inc.
5 employees
CEO: Christopher J. Moreau
Grey Matters Health, Inc. is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them into new human trials, developing new formulation...